Wolverine Trading’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $959K | Sell |
4,298
-6,058
| -58% | -$1.23M | ﹤0.01% | 2946 |
|
|
2025
Q2 | $1.89M | Buy |
+10,356
| New | +$1.92M | ﹤0.01% | 1752 |
|
|
2025
Q1 | – | Sell |
-67,867
| Closed | -$12M | – | 4628 |
|
|
2024
Q4 | $12M | Buy |
67,867
+55,351
| +442% | +$10.2M | 0.01% | 697 |
|
|
2024
Q3 | $2.44M | Sell |
12,516
-143,847
| -92% | -$26.8M | ﹤0.01% | 1541 |
|
|
2024
Q2 | $26.8M | Buy |
156,363
+6,194
| +4% | +$1.03M | 0.03% | 322 |
|
|
2024
Q1 | $27.3M | Buy |
150,169
+12,303
| +9% | +$2.12M | 0.03% | 329 |
|
|
2023
Q4 | $21.4M | Buy |
137,866
+26,119
| +23% | +$3.81M | 0.02% | 434 |
|
|
2023
Q3 | $16.7M | Buy |
111,747
+77,855
| +230% | +$11.4M | 0.02% | 436 |
|
|
2023
Q2 | $4.52M | Buy |
33,892
+20,390
| +151% | +$2.99M | 0.01% | 967 |
|
|
2023
Q1 | $2.13M | Sell |
13,502
-803,440
| -98% | -$123M | ﹤0.01% | 1331 |
|
|
2022
Q4 | $132M | Buy |
816,942
+809,622
| +11,060% | +$124M | 0.2% | 65 |
|
|
2022
Q3 | $1.04M | Buy |
+7,320
| New | +$1.05M | ﹤0.01% | 1925 |
|
|
2022
Q2 | – | Sell |
-49,819
| Closed | -$7.61M | – | 4352 |
|
|
2022
Q1 | $8.16M | Sell |
49,819
-46,223
| -48% | -$6.71M | 0.01% | 785 |
|
|
2021
Q4 | $13.1M | Buy |
96,042
+50,273
| +110% | +$5.94M | 0.02% | 608 |
|
|
2021
Q3 | $4.98M | Sell |
45,769
-13,505
| -23% | -$1.54M | 0.01% | 1299 |
|
|
2021
Q2 | $6.66M | Buy |
59,274
+20,116
| +51% | +$2.27M | 0.01% | 919 |
|
|
2021
Q1 | $4.18M | Sell |
39,158
-86,328
| -69% | -$9.23M | 0.01% | 1276 |
|
|
2020
Q4 | $13.2M | Buy |
125,486
+68,809
| +121% | +$6.61M | 0.02% | 552 |
|
|
2020
Q3 | $4.92M | Buy |
56,677
+24,103
| +74% | +$2.27M | 0.01% | 863 |
|
|
2020
Q2 | $3.14M | Buy |
32,574
+2,573
| +9% | +$227K | 0.01% | 1089 |
|
|
2020
Q1 | $2.26M | Sell |
30,001
-185,763
| -86% | -$15.8M | 0.01% | 1255 |
|
|
2019
Q4 | $19.1M | Buy |
215,764
+140,448
| +186% | +$11.7M | 0.05% | 384 |
|
|
2019
Q3 | $5.64M | Buy |
75,316
+27,104
| +56% | +$1.86M | 0.02% | 803 |
|
|
2019
Q2 | $3.51M | Buy |
48,212
+44,684
| +1,267% | +$3.51M | 0.01% | 1130 |
|
|
2019
Q1 | $284K | Sell |
3,528
-41,978
| -92% | -$3.43M | ﹤0.01% | 3424 |
|
|
2018
Q4 | $4.15M | Buy |
45,506
+28,847
| +173% | +$2.54M | 0.01% | 929 |
|
|
2018
Q3 | $1.58M | Sell |
16,659
-51,235
| -75% | -$4.86M | ﹤0.01% | 1896 |
|
|
2018
Q2 | $6.43M | Hold |
67,894
| – | – | 0.02% | 714 |
|
|
2018
Q1 | $6.43M | Sell |
67,894
-15,896
| -19% | -$1.75M | 0.02% | 714 |
|
|
2017
Q4 | $8.1M | Buy |
+83,790
| New | +$7.9M | 0.03% | 602 |
|
|
2017
Q2 | – | Sell |
-28,340
| Closed | -$1.85M | – | 4183 |
|
|
2017
Q1 | $1.85M | Buy |
28,340
+23,091
| +440% | +$1.45M | 0.01% | 1241 |
|
|
2016
Q4 | $329K | Buy |
+5,249
| New | +$320K | ﹤0.01% | 3150 |
|
|
2016
Q3 | – | Sell |
-30,078
| Closed | -$1.95M | – | 4557 |
|
|
2016
Q2 | $1.86M | Buy |
+30,078
| New | +$1.83M | 0.01% | 1152 |
|
Other funds holding ABBV
Wolverine Trading's ABBV Position: Q3 2025 in Review
Wolverine Trading reduced its AbbVie (ABBV) stake by 58% in Q3 2025, selling an estimated $1.23M and leaving 4,298 shares worth $959K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.
Wolverine Trading first reported a position in ABBV in Q2 2016 and has held it in 33 quarters since. The position peaked at $132M in Q4 2022. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Wolverine Trading held 4,298 shares of AbbVie worth $959K as of Q3 2025.
- Wolverine Trading sold 6,058 AbbVie shares in Q3 2025, an estimated $1.23M.
- AbbVie made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2946 holding.
- Wolverine Trading first reported a position in AbbVie in Q2 2016 and has held it in 33 quarters since.
- Wolverine Trading's AbbVie position peaked at $132M in Q4 2022.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.